Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
NEW YORK (Reuters Health) – Muscle pain and weakness in patients taking statins often reflect true muscle damage, new research shows. Moreover, real muscle injury may exist even…
NEW YORK (Reuters Health) – New research suggests that regardless of how hormone therapy is given, it increases the risk of ovarian cancer. “Our study suggests an increased…
NEW YORK (Reuters Health) – A further analysis of data from the Women’s Health Initiative (WHI) trials indicates that the risks of hormone therapy still generally outweigh the…
NEW YORK (Reuters Health) – In a prospective, randomized trial, a single daily tablet containing efavirenz, emtricitabine, and tenofovir (Atripla; Bristol Myers Squibb & Gilead Sciences LLC) maintained…
John Flaherty, MD, Professor of Medicine, Northwestern University, discusses HIV infection, latest trends in treatment and what a hospitalist needs to know. Summary: 1.There is a trend toward…
NEW YORK (Reuters Health) – New research indicates that when given to women in labor, allopurinol crosses the placenta during fetal hypoxia and may help reduce brain injury.…
NEW YORK (Reuters Health) – New research suggests that treatment with methylphenidate and other stimulants may help prevent the development of comorbid psychiatric disorders, as well as improve…
NEW YORK (Reuters Health) – In patients with unresectable pancreatic cancer, the combination of gemcitabine and a novel cationic liposomal formulation of paclitaxel called EndoTAG-1 substantially prolongs survival…
NEW YORK (Reuters Health) – In a phase III study of patients with progressive well-differentiated pancreatic islet cell tumors, treatment with the tyrosine kinase inhibitor sunitinib significantly prolonged…
NEW YORK (Reuters Health) – Dementia and use of dopaminergic agents, principally pergolide, are risk factors for psychotic symptoms in patients with Parkinson’s disease, according to a report…
